- Home
- LITB vs ATRA Comparison
LITB vs ATRA Comparison
Compare LITB & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LITB | ATRA |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.2M | 38.9M |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LITB | ATRA |
|---|---|---|
| Price | $2.43 | $5.10 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 6.1K | ★ 296.7K |
| Earning Date | 03-24-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | N/A | ★ 2.57 |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.96 | ★ $1.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $3.92 |
| 52 Week High | $4.17 | $19.15 |
Technical Indicators
Market Signals| Indicator | LITB | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 44.04 |
| Support Level | $2.42 | $4.27 |
| Resistance Level | $2.96 | $5.80 |
| Average True Range (ATR) | 0.12 | 0.69 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 11.11 | 14.61 |
Price Performance
Historical ComparisonAbout LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).